Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]
Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]
Now that spring is officially here, many of us are excitedly waiting until we can get outside and into our balcony or backyard gardens. The pandemic has made outdoor interests […]
MEET THE CMC FACULTY Dr. Cathy Craven University of Toronto Toronto, ON Cathy Craven is the Toronto Rehabilitation Institute/ University of Toronto Chair in Spinal Cord Injury (SCI) Rehabilitation, Professor […]
Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]
BONE MINERAL DENSITY TEST A BMD test can tell you whether or not you have osteoporosis Why Should I Get Tested? A risk factor assessment is an important first step […]
Medications that can Cause Bone Loss, Falls and/or Fractures A variety of medications can increase bone loss and/or fall risk: Synthetic Glucocorticoids (e.g. Prednisone) Glucocorticoids are produced naturally by the […]
Volunteer of Distinction Award Form The Volunteer of Distinction Award is to honour an individual who has made an exceptional and sustained contribution to Osteoporosis Canada and has demonstrated outstanding […]
Our Senior Team Dr. Famida Jiwa President and CEO Dr. Jiwa is the President and CEO of Osteoporosis Canada, and has been with the organization since 2006. Prior to joining […]